Overview
As antibiotic resistance escalates, phage therapy is re-emerging as a precise and adaptable alternative to conventional treatments. This book presents a comprehensive exploration of bacteriophages—viruses that infect and destroy bacteria—and their therapeutic potential in modern medicine. It covers key aspects of phage biology, design, and delivery, including advanced strategies that combine phages with antibiotics, immunotherapy, and photodynamic approaches. The text also addresses production standards, safety protocols, and regulatory frameworks essential for clinical translation. Drawing on global case studies and recent clinical trials, the book illustrates both the promise and complexity of deploying phage therapy against resistant infections. Future-facing chapters explore personalized phage medicine, AI-driven phage selection, and integration into broader antimicrobial strategies. Written for researchers, clinicians, and graduate students in microbiology, pharmacology, and biomedical sciences, this volume bridges foundational science with translational insight. It is a timely and authoritative resource for those advancing targeted solutions in the fight against superbugs.
Full Product Details
Author: Chuanbin Mao (University of Oklahoma, USA)
Publisher: Royal Society of Chemistry
Imprint: Royal Society of Chemistry
Dimensions:
Width: 15.60cm
, Height: 2.20cm
, Length: 23.40cm
Weight: 0.730kg
ISBN: 9781837072019
ISBN 10: 1837072019
Pages: 384
Publication Date: 22 April 2026
Audience:
Professional and scholarly
,
Professional & Vocational
Format: Hardback
Publisher's Status: Forthcoming
Availability: Not yet available
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.
Author Information
Professor Chuanbin Mao is a Global STEM Professor at the Chinese University of Hong Kong and the Director of the Jockey Club STEM Lab for Nature-Inspired Precision Medical Engineering. An elected fellow of numerous prestigious societies—including the American Association for the Advancement of Science (AAAS), the American Academy of Microbiology (AAM), the American Chemical Society (ACS), the Royal Society of Chemistry (RSC), the American Institute for Medical and Biological Engineering (AIMBE), and International Academy of Medical and Biological Engineering (IAMBE)—he is a leading expert in applying phage biology to modern medicine. His seminal contributions involve using phages to develop novel biomaterials. He has authored over 300 peer-reviewed publications in top-tier journals such as Chemical Reviews, Science, Nature Materials, and Nature Nanotechnology. His groundbreaking work focuses on genetically engineering phages for use as biomaterials in biosensing, nanomedicine, regenerative medicine, and antimicrobial therapy. He is a recipient of the US National Science Foundation CAREER Award, among other awards.
